Literature DB >> 22284533

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

B Teh1, M L Grayson, P D R Johnson, P G P Charles.   

Abstract

We assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either 'atypical' (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22284533     DOI： 10.1111/j.1469-0691.2011.03759.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  6 in total

1.  Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia.

Authors:  Moe Uddin; Turab Mohammed; Mark Metersky; Antonio Anzueto; Carlos A Alvarez; Eric M Mortensen
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway.

Authors:  Norika Chiba; Kenichi Shimada; Shuang Chen; Heather D Jones; Randa Alsabeh; Anatoly V Slepenkin; Ellena Peterson; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2015-03-09       Impact factor: 5.422

3.  Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis.

Authors:  Madhulika Jupelli; Kenichi Shimada; Norika Chiba; Anatoly Slepenkin; Randa Alsabeh; Heather D Jones; Ellena Peterson; Shuang Chen; Moshe Arditi; Timothy R Crother
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

4.  Autophagy Limits Inflammasome During Chlamydia pneumoniae Infection.

Authors:  Timothy R Crother; Rebecca A Porritt; Jargalsaikhan Dagvadorj; Gantsetseg Tumurkhuu; Anatoly V Slepenkin; Ellena M Peterson; Shuang Chen; Kenichi Shimada; Moshe Arditi
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 5.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

6.  Adherence to Treatment Guideline Improves Patient Outcomes in a Prospective Cohort of Adults Hospitalized for Community-Acquired Pneumonia.

Authors:  Grace Lui; Heather K W To; Nelson Lee; Renee W Y Chan; Timothy Li; Rity Y K Wong; David S C Hui; Margaret Ip
Journal:  Open Forum Infect Dis       Date:  2020-04-24       Impact factor: 3.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.